Goddard Glenn 4
4 · Intellia Therapeutics, Inc. · Filed Jan 6, 2023
Insider Transaction Report
Form 4
Goddard Glenn
EVP, Chief Financial Officer
Transactions
- Sale
Common Stock
2023-01-04$37.21/sh−2,427$90,309→ 15,404 total
Footnotes (1)
- [F1]Shares sold in sell-to-cover transaction in order to satisfy withholding taxes to be paid upon the vesting of RSUs on January 1, 2023.